TNK Dose in Large-Vessel Stroke: 0.25 mg/kg Is Sufficient TNK Dose in Large-Vessel Stroke: 0.25 mg/kg Is Sufficient
New data from a second EXTEND-IA TNK (tenecteplase) trial clarify the optimum dose of the bolus thrombolytic for use in ischemic stroke, for which enthusiasm is growing.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 20, 2020 Category: Cardiology Tags: Neurology & Neurosurgery News Source Type: news

Assessing Hemocompatibility for Medical Devices in Contact with Circulating Blood
Many commonly used medical devices, such as catheters, cardiopulmonary bypass systems, and endovascular grafts, are intended to come in contact with circulating blood. Therefore, these devices require an assessment for hemocompatibility risks such as hemolysis and thrombosis prior to submitting to a regulatory agency for market approval. The testing required for the evaluation of these specific endpoints depends on the exposure type and duration of the specific medical device under focus, and the guidance is captured in Table 1 of ISO 10993-4 Biological evaluation of medical devices - Part 4: Selection of tests for interac...
Source: MDDI - February 20, 2020 Category: Medical Devices Authors: Helin R äägel Tags: Testing Source Type: news

Abbott ’s Coronary Dilation Catheters Face Class I Recall
Abbott Laboratories is facing a Class I Recall of its coronary dilation catheters. The Abbott Park, IL-based company said that “certain lots” of the NC Trek RX Coronary Dilatation Catheter would be impacted by the recall. According to FDA’s website the firm field personnel and Affiliates directly contacted the first customers beyond the firm's control via phone, email, or personal visit to facilitate rapid notification, Jan. 29, 2020. The "URGENT MEDICAL DEVICE RECALL" Notification informed customers that specific lots of its Coronary Dilatation Catheters with...
Source: MDDI - February 20, 2020 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Renal Function Change Found to be a Prognostic Factor for Cancer Specific Survival in RCC
The aim of this Chinese study was to evaluate the influencing factors of perioperative renal function change and their relationship with prognosis in patients with renal cell carcinoma and tumor thrombus after nephrectomy and thrombectomy. (Source: CancerNetwork)
Source: CancerNetwork - February 9, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Arterial Stiffness Increased Within Year of Final Menstrual Period
FRIDAY, Feb. 7, 2020 -- Changes in arterial stiffness are greater within one year of a woman's final menstrual period (FMP), according to a study published online Jan. 23 in Arteriosclerosis, Thrombosis, and Vascular Biology. Saad Samargandy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 7, 2020 Category: Pharmaceuticals Source Type: news

Aneurysm Diameter, Intraluminal Thrombus Predict AAA Growth
THURSDAY, Feb. 6, 2020 -- Maximum diameter and presence of intraluminal thrombus (ILT) are independent predictors of abdominal aortic aneurysm (AAA) growth, according to a study published online Jan. 28 in Radiology. Chengcheng Zhu, Ph.D., from the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 6, 2020 Category: Pharmaceuticals Source Type: news

What interventional radiologists need to know about frostbite and amputation
(American Roentgen Ray Society) An ahead-of-print article in the April issue of the American Journal of Roentgenology (AJR) reviewing various techniques and clinical management paradigms to treat severe frostbite injuries -- relevant for interventional radiology, especially--showed promising results using both intraarterial and intravenous tissue plasminogen activator to reduce amputation. AJR's meta-analysis of thrombolytic therapy updates the guidelines for all interventional radiologists, including a suggested protocol, inclusion and exclusion criteria, and potential complications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 6, 2020 Category: International Medicine & Public Health Source Type: news

Presence of Blood Clot Tied to Accelerated AAA Progression Presence of Blood Clot Tied to Accelerated AAA Progression
The maximal diameter of an abdominal aortic aneurysm (AAA) and the presence of an intraluminal thrombus (ILT) are both independent predictors of faster aneurysm growth, according to a new study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - February 6, 2020 Category: Radiology Tags: Cardiology News Source Type: news

rt-PA in Ischemic Stroke After Idarucizumab Administration rt-PA in Ischemic Stroke After Idarucizumab Administration
This case demonstrates that thrombolytic therapy with rt-PA after reversal of dabigatran with idarucizumab may be safe and feasible in patients with acute ischemic stroke with lacunar infarct.Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 4, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news

Oral anticoagulants cost effective for thrombosis prevention in cancer
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2020 Category: Drugs & Pharmacology Source Type: news

Tailored Doses of Enoxaparin Better Prevent VTE After Cancer Surgery Tailored Doses of Enoxaparin Better Prevent VTE After Cancer Surgery
Adjusting the doses of enoxaparin based on anti-Xa levels, instead of using standard doses, may better prevent venous thromboembolism (VTE) without worsening bleeding rates in patients undergoing abdominal cancer surgery, according to a new study.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 18, 2020 Category: Surgery Tags: General Surgery News Source Type: news

Guidance Issued for Hepatic, Mesenteric Circulation Disorders
Recommendations address bleeding and thrombotic risk in cirrhosis; portal, mesenteric vein thrombosis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - January 13, 2020 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Pathology, Pharmacy, Radiology, Journal, Source Type: news

Anticoagulant chemoprophylaxis in patients with traumatic brain injuries: a systematic review - Spano PJ, Shaikh S, Boneva D, Hai S, McKenney M, Elkbuli A.
BACKGROUND: Traumatic brain injury (TBI) continues to be a deadly injury. Universally accepted guidelines regarding the use of venous thromboembolism (VTE) chemoprophylaxis in trauma patients presenting with TBI have not been established. The purpose of th... (Source: SafetyLit)
Source: SafetyLit - January 13, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Metabolic Syndrome May Up Risk for VTE Recurrence After DVT
THURSDAY, Jan. 9, 2020 -- For patients with deep vein thrombosis (DVT), the presence of any component of metabolic syndrome (MetS) is independently associated with an increased risk for venous thromboembolism (VTE) recurrence, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 9, 2020 Category: Pharmaceuticals Source Type: news

PICCs Increase Thromboembolism Risk in Children PICCs Increase Thromboembolism Risk in Children
Use of peripherally inserted central catheters in children was associated with a greater risk for venous thrombosis, a study found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 7, 2020 Category: Consumer Health News Tags: Pediatrics News Source Type: news

Risk for Blood Clots Increased With PICC Placement in Children
TUESDAY, Jan. 7, 2020 -- Central venous catheter (CVC) placement with peripherally inserted central catheters (PICCs) in children is associated with increased risks for venous thromboembolism (VTE), central line-associated bloodstream infection... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 7, 2020 Category: Pharmaceuticals Source Type: news

Trauma Embolic Scoring System in military trauma: a sensitive predictor of venous thromboembolism - Walker PF, Schobel S, Caruso JD, Rodriguez CJ, Bradley MJ, Elster EA, Oh JS.
INTRODUCTION: Clinical decision support tools capable of predicting which patients are at highest risk for venous thromboembolism (VTE) can assist in guiding surveillance and prophylaxis decisions. The Trauma Embolic Scoring System (TESS) has been shown to... (Source: SafetyLit)
Source: SafetyLit - January 6, 2020 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

NASA Astronaut Had The First Known Blood Clot In Space
(CNN) — When astronauts encounter a medical risk on the International Space Station 250 miles up from the Earth’s surface, it’s not exactly easy for a doctor to make a house call. So when NASA researchers suspected a blood clot in one of their astronauts during a long-duration stay on the space station last year, they had to act quickly to treat the unexpected risk. The blood clot was detected during a vascular study of 11 astronauts on the station to assess the effect of space on the internal jugular vein. In zero gravity, astronauts’ blood and tissue fluid shifts toward the head. The study involve...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - January 5, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Offbeat Syndicated CBSN Boston CNN International Space Station NASA Source Type: news

UNC expert helps treat astronaut's blood clot during NASA mission
(University of North Carolina Health Care) Moll was the only non-NASA physician NASA consulted when it was discovered that an astronaut aboard the ISS had a deep vein thrombosis (DVT) -- or blood clot -- in the jugular vein of their neck. Moll co-wrote a case study on the successful treatment that has been published in the New England Journal of Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 2, 2020 Category: International Medicine & Public Health Source Type: news

Deep Vein Thrombosis Risk Declines After Bariatric Surgery Deep Vein Thrombosis Risk Declines After Bariatric Surgery
Bariatric surgery is associated with a significant decrease in the long-term risk of venous thromboembolic events (VTEs), principally deep vein thrombosis (DVT), according to findings from the UK Clinical Practice Research Datalink (CPRD).Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 31, 2019 Category: Consumer Health News Tags: General Surgery News Source Type: news

Pregnant Women Can Reduce Thrombosis Risk on Flights Pregnant Women Can Reduce Thrombosis Risk on Flights
Pregnant air travelers face a higher risk of blood clots, but they can reduce their risks by walking airplane aisles, drinking water and doing calf exercises, according to a new review.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 27, 2019 Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health News Source Type: news

FDA approves first generics of Eliquis
The U.S. Food and Drug Administration has approved two applications for the first generics of Eliquis (apixaban) tablets to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. Apixaban is also indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. (Source: World Pharma News)
Source: World Pharma News - December 26, 2019 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Mindfulness: A New Approach to the Nursing Shortage Crisis
By Ebahi Ikharo, 2019 UNC-IntraHealth Summer FellowDecember 16, 2019Just outside Windhoek, Namibia, I stood in the maternity ward of Windhoek Central Hospital. Filling the lime green halls were students, nurses, midwives, doctors, clients in motion, and the groans of a mother in labor.I was there as part of my UNC-IntraHealth summer fellowship to support the Nursing Now Namibia Campaign, building a tool to help identify gaps in compliance to hospital standards on the maternity floor and provide recommendations for areas of improvement. I had the opportunity to visit three hospitals and interview nine nurses.It is very tr...
Source: IntraHealth International - December 16, 2019 Category: International Medicine & Public Health Authors: mnathe Tags: Mental Health Nursing & Midwifery Nurses Source Type: news

Study finds African Americans with cancer at higher risk for blood clots
(Boston University School of Medicine) African-Americans are at higher risk for cancer-associated venous thromboembolism (VTE) as compared with patients from other races. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - December 16, 2019 Category: Cancer & Oncology Source Type: news

Venous thrombosis after nitrous oxide abuse, a case report - Pratt DN, Patterson KC, Quin K.
We present a 21-year-old female with no medical history who presente... (Source: SafetyLit)
Source: SafetyLit - December 12, 2019 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Using Injury Severity Score and Abbreviated Injury Score to determine venous thromboembolism risk - Hereford T, Thrush C, Kimbrough MK.
This study investigated whether the Injury Severity Score (ISS) could be used in conjunc... (Source: SafetyLit)
Source: SafetyLit - December 7, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Espina conducting thrombus proteomic analysis
(George Mason University) Virginia Espina, Research Associate Professor, Applied Proteomics and Molecular Medicine, received $7,637 from Mayo Clinic for: 'Thrombus proteomic analysis.' (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 6, 2019 Category: International Medicine & Public Health Source Type: news

Risk of venous thromboembolism after carbon  monoxide poisoning: a nationwide population-based study - Cho Y, Kang H, Oh J, Lim TH, Ryu J, Ko BS.
STUDY OBJECTIVE: Few studies have investigated the association between carbon monoxide (CO) poisoning and risk of venous thromboembolism. We aim to identify the risk of pulmonary embolism and deep venous thrombosis after CO poisoning. METHODS: We c... (Source: SafetyLit)
Source: SafetyLit - November 27, 2019 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

25.11.19: Not intended for U.S. and UK Media
Bayer submits application to EMA for use of rivaroxaban in children with venous thromboembolismAdding treatment of venous thromboembolism (VTE) and prevention of VTE recurrence in children from birth to 17 years of age with confirmed VTE, including cerebral vein and sinus thrombosis / Submission based on results from phase 3 EINSTEIN-Jr. study showing convincing efficacy and safety profile for rivaroxaban in children with VTE / An oral liquid formulation of rivaroxaban that does not require injections and regular monitoring was developed to facilitate pediatric administration / Patent extension in Europe of six months will...
Source: Bayer IR Newsfeed: Events - November 25, 2019 Category: Pharmaceuticals Source Type: news

Bayer submits application to EMA for use of rivaroxaban in children with venous thromboembolism (for specialized target groups only)
Adding treatment of venous thromboembolism (VTE) and prevention of VTE recurrence in children from birth to 17 years of age with confirmed VTE, including cerebral vein and sinus thrombosis / Submission based on results from phase 3 EINSTEIN-Jr. study showing convincing efficacy and safety profile for rivaroxaban in children with VTE / An oral liquid formulation of rivaroxaban that does not require injections and regular monitoring was developed to facilitate pediatric administration / Patent extension in Europe of six months will be applied for once the procedure is completed (Source: Bayer Company News)
Source: Bayer Company News - November 25, 2019 Category: Pharmaceuticals Source Type: news

Rheumatoid Arthritis Linked to Comorbidities Before, After Diagnosis
WEDNESDAY, Nov. 20, 2019 -- There are associations between rheumatoid arthritis (RA) and multiple comorbidities before and after diagnosis, with inflammatory bowel disease, type 1 diabetes, and venous thromboembolism (VTE) occurring more often... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 20, 2019 Category: Pharmaceuticals Source Type: news

Increased VTE Risk With Testosterone Therapy Increased VTE Risk With Testosterone Therapy
Men with and without hypogonadism have an increased risk of venous thromboembolism (VTE) with testosterone therapy, according to a case-crossover study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2019 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Testosterone Therapy Tied to Increase in Short-Term VTE Risk
TUESDAY, Nov. 12, 2019 -- For men with and without hypogonadism, testosterone therapy is associated with an increased short-term risk for venous thromboembolism (VTE), according to a study published online Nov. 11 in JAMA Internal Medicine. Rob F.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 12, 2019 Category: Pharmaceuticals Source Type: news

Thrombosis | Medscape Thrombosis | Medscape
(Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 11, 2019 Category: Consumer Health News Tags: Resource Center Source Type: news

Many take anticoagulants and OTC supplements, which poses risk
FINDINGSNearly 98% percent of people prescribed direct-acting oral anticoagulants such as apixaban also used  over-the-counter products. Of those, 33% took at least one such product that, in combination with the anticoagulants, could cause dangerous internal bleeding. People taking these medications largely lacked knowledge of some potentially serious interactions.BACKGROUNDDirect-acting oral anticoagulants are the drug of choice for stroke prevention in patients with atrial fibrillation, which occurs most frequently in older patients. Apixaban is one of the most frequently prescribed. However, most people prescribed ...
Source: UCLA Newsroom: Health Sciences - November 1, 2019 Category: Universities & Medical Training Source Type: news

Rivaroxaban Misfires in Antiphospholipid Syndrome Rivaroxaban Misfires in Antiphospholipid Syndrome
Rivaroxaban not only failed to show noninferiority to warfarin, but trended toward higher thrombosis risk in patients with APS.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - October 17, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

FDA Approves Xarelto (rivaroxaban) to Help Prevent Blood Clots in Acutely Ill Medical Patients
RARITAN, N.J., October 14, 2019– The Janssen Pharmaceutical Companies of Johnson& Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved Xarelto (rivaroxaban) for the prevention of venous thromboembolism... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 14, 2019 Category: Drugs & Pharmacology Source Type: news

14.10.19: Not intended for U.S. and UK Media
U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patientsA new oral option for patients in the U.S. with acute medical illnesses at risk for thromboembolic complications who are not at high risk of bleeding / Rivaroxaban is the only non vitamin K antagonist oral anticoagulant (NOAC) approved in the U.S for the continuum of venous thromboembolism (VTE) care, from prevention and treatment of initial VTE through extended prevention of recurrent VTEmehr ... (Source: Bayer IR Newsfeed: Events)
Source: Bayer IR Newsfeed: Events - October 14, 2019 Category: Pharmaceuticals Source Type: news

Nigeria: World Thrombosis Day - Why Air Travellers Face Greater Risk, Especially With Alcohol - - Expert
[Premium Times] Air travellers face increased risk of thrombosis and should pay more attention to condition that involves poor blood flow and clotting, a haematologist has said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 14, 2019 Category: African Health Source Type: news

U.S. FDA Approves XARELTO ® (rivaroxaban) to Help Prevent Blood Clots in Acutely Ill Medical Patients
XARELTO ® provides a new oral option to help prevent venous thromboembolism (VTE) and VTE-related death during hospitalization and post-hospital discharge in acutely ill medical patients at risk for VTE and not at high risk of bleedingDespite being largely preventable, VTE, or blood clots, remains a signif icant risk for millions of Americans hospitalized with an acute medical illness (Source: Johnson and Johnson)
Source: Johnson and Johnson - October 14, 2019 Category: Pharmaceuticals Source Type: news

U.S. FDA approves rivaroxaban to help prevent blood clots in acutely ill medical patients (for specialized target groups only)
A new oral option for patients in the U.S. with acute medical illnesses at risk for thromboembolic complications who are not at high risk of bleeding / Rivaroxaban is the only non vitamin K antagonist oral anticoagulant (NOAC) approved in the U.S for the continuum of venous thromboembolism (VTE) care, from prevention and treatment of initial VTE through extended prevention of recurrent VTE (Source: Bayer Company News)
Source: Bayer Company News - October 14, 2019 Category: Pharmaceuticals Source Type: news

Sky Medical Technology Nabs FDA Clearance for VTE Device
Sky Medical Technology Ltd. won FDA clearance for a device that stimulates calf muscles to prevent venous thrombosis in non-surgical patients at risk for venous thromboembolism. The Daresbury, England-based company said the geko device is the first muscle pump activator of its kind to be cleared by FDA for VTE prevention across all patients. Sky Medical Technology’s geko is a non-invasive battery-powered, wearable therapy device that is about the size of wristwatch. The technology is worn at the knee. Geko works by gently stimulating the common peroneal nerve, activating the calf and foot muscle pumps, re...
Source: MDDI - October 12, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

Penumbra Looks to Bolster Indigo Through CHEETAH
The first patient has been enrolled in Penumbra’s CHEETAH post-market study to evaluate the Indigo System with CAT RX Aspiration Catheter in the coronary vessels. About 400 patients are expected to be enrolled at 25 centers in CHEETAH. Alameda, CA-based Penumbra’s Indigo System uses mechanical power aspiration to remove thrombus in the coronaries. The primary study endpoint is a composition of cardiovascular (CV) death, recurrent myocardial infarction (MI), cardiogenic shock or new or worsening New York Heart Association (NYHA) Class IV heart failure within 30 days. Secondary endpoints i...
Source: MDDI - October 11, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

FDA Clears GEKO DEVICE for Use in Non-surgical Patients at Risk for Deep Vein Thrombosis Based on Study Demonstrating a Zero Percent DVT Rate in Patients After a Stroke
Sky Medical Technology furthers presence in 3.5bn1 dollar US market for VTE prevention DARESBURY, England, Oct. 10, 2019 -- (Healthcare Sales & Marketing Network) -- UK-based medical devices company, Sky Medical Technology Ltd, has received U.S. Food a... Devices, FDA Sky Medical Technology, geko, Deep Vein Thrombosis, venous thromboembolism (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 10, 2019 Category: Pharmaceuticals Source Type: news

Africa: World Thrombosis Day Empowers People Around the World to Recognize and Help Prevent Life-Threatening Blood Clots
[PR Newswire] Chapel Hill, North Carolina -On October 13, the World Thrombosis Day campaign shares an important message: patients, regardless of where they live, should be able to to expect that their hospital stay is safe and that the risk of adverse events such as thrombosis is minimized. Thrombosis is the formation of potentially deadly blood clots in an artery or vein. With one in four deaths due to thrombosis-related conditions each year, the campaign encourages health systems to have risk assessment protocols in place and patients to be infor (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - October 9, 2019 Category: African Health Source Type: news

Thrombus Imaging in Acute Stroke: Are We Even Close? Thrombus Imaging in Acute Stroke: Are We Even Close?
Can imaging characteristics of thrombi provide predictive value or useful information for planning endovascular procedures?Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2019 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news

AngioDynamics Has Laser Focus on PAD with New Acquisition
The M&A’s just keep coming this week as AngioDynamics announced a plan acquire Eximo Medical. Latham, NY-based AngioDynamics will pick up the company for about $46 million in up-front consideration with the possibility of up to $20 million in milestones. The announcement comes a day after Lantheus Holdings revealed its intention to acquire Progenics Pharmaceuticals. Eximo has developed technology that delivers short, high-powered pulsed-laser energy in 355nm wavelength without compromising the integrity of its fiber optic cables during atherectomy procedures. The technology addresses the risk of perfo...
Source: MDDI - October 3, 2019 Category: Medical Devices Authors: Omar Ford Tags: Business Cardiovascular Source Type: news

PARTNER 3: Leaflet Thrombosis Often Resolves, the Questions Haven't PARTNER 3: Leaflet Thrombosis Often Resolves, the Questions Haven't
The CT substudy was'mandated by the FDA to answer this question about valve thrombosis, and I think it's gone a long way toward doing that, but not completely answered it,'a trialist says.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - October 2, 2019 Category: Radiology Tags: Cardiology News Source Type: news

Boston Scientific ’s Shining Moment at TCT
Perhaps one of Boston Scientific’s greatest moments at the 31st Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation, came when the company announced primary endpoint results from the EVOLVE Short DAPT clinical trial. The Marlborough, MA-based company said the trial evaluated its Synergy Bioabsorbable Polymer (BP) stent and that the EVOLVE is first prospective study initiated in the U.S. to examine the safety of a shortened duration of dual antiplatelet therapy (DAPT) in patients at high risk for bleeding. Results and demonstrated that ...
Source: MDDI - September 30, 2019 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Source Type: news

Rivaroxaban Cuts Recurrent Blood Clots in Obese Patients
MONDAY, Sept. 30, 2019 -- Real-world evidence shows that rivaroxaban reduces the risk for recurrent venous thromboembolism (VTE) in morbidly obese patients, with similar safety and efficacy as warfarin, according to a study published in the October... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - September 30, 2019 Category: Pharmaceuticals Source Type: news